Kiykim, A. Et Al. 2019. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.7, no.8 , 2790-2815.

Kiykim, A., ÖĞÜLÜR, İ., Dursun, E., Charbonnier, L. M., Nain, E., Cekic, S., ... DOĞRUEL, D.(2019). Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.7, no.8, 2790-2815.

Kiykim, Ayca Et Al. "Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency," JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.7, no.8, 2790-2815, 2019

Kiykim, Ayca Et Al. "Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency." JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.7, no.8, pp.2790-2815, 2019

Kiykim, A. Et Al. (2019) . "Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency." JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.7, no.8, pp.2790-2815.

@article{article, author={Ayca Kiykim Et Al. }, title={Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency}, journal={JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}, year=2019, pages={2790-2815} }